Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pigott

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|April 1, 1991
Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladderL M Coombs, D A Pigott, E Sweeney, et al.
Biological Psychiatry|January 1, 1993
A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPPT A Pigott, J L Hill, T A Grady, et al.
Carcinogenesis|September 1, 1988
A metabolite of the carcinogen 7,12-dimethylbenz[a]anthracene that reacts predominantly with adenine residues in DNAS C Cheng, A S Prakash, M A Pigott, et al.
The American Journal of Psychiatry|November 1, 1991
Symptoms of eating disorders in patients with obsessive-compulsive disorderT A Pigott, M Altemus, C S Rubenstein, et al.
Psychiatry Research|October 1, 1993
Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: a pilot studyM A Demitrack, F W Putnam, D R Rubinow, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 25, 2020
Higher Prevalence of Metabolic Syndrome in Child-adolescent Patients with Bipolar DisorderSatyajit Mohite, Hanjing Wu, Shiva Sharma, et al.
Psychopharmacology Bulletin|January 1, 1989
Neurohypophyseal dysfunction: implications for the pathophysiology of eating disordersM A Demitrack, M D Lesem, H A Brandt, et al.
Journal of Clinical Psychopharmacology|August 1, 1991
A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorderT A Pigott, M T Pato, F L'Heureux, et al.
Archives of General Psychiatry|October 1, 1990
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological resultsT A Pigott, M T Pato, S E Bernstein, et al.
Biological Psychiatry|March 1, 1991
Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorderT A Pigott, J Zohar, J L Hill, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|April 1, 1991
Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladderL M Coombs, D A Pigott, E Sweeney, et al.
Biological Psychiatry|January 1, 1993
A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPPT A Pigott, J L Hill, T A Grady, et al.
Carcinogenesis|September 1, 1988
A metabolite of the carcinogen 7,12-dimethylbenz[a]anthracene that reacts predominantly with adenine residues in DNAS C Cheng, A S Prakash, M A Pigott, et al.
The American Journal of Psychiatry|November 1, 1991
Symptoms of eating disorders in patients with obsessive-compulsive disorderT A Pigott, M Altemus, C S Rubenstein, et al.
Psychiatry Research|October 1, 1993
Relation of dissociative phenomena to levels of cerebrospinal fluid monoamine metabolites and beta-endorphin in patients with eating disorders: a pilot studyM A Demitrack, F W Putnam, D R Rubinow, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 25, 2020
Higher Prevalence of Metabolic Syndrome in Child-adolescent Patients with Bipolar DisorderSatyajit Mohite, Hanjing Wu, Shiva Sharma, et al.
Psychopharmacology Bulletin|January 1, 1989
Neurohypophyseal dysfunction: implications for the pathophysiology of eating disordersM A Demitrack, M D Lesem, H A Brandt, et al.
Journal of Clinical Psychopharmacology|August 1, 1991
A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated patients with obsessive-compulsive disorderT A Pigott, M T Pato, F L'Heureux, et al.
Archives of General Psychiatry|October 1, 1990
Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological resultsT A Pigott, M T Pato, S E Bernstein, et al.
Biological Psychiatry|March 1, 1991
Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorderT A Pigott, J Zohar, J L Hill, et al.
Pageof 8